-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on 10x Genomics, Raises Price Target to $18

Benzinga·01/07/2026 18:07:53
语音播报
TD Cowen analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Hold and raises the price target from $15 to $18.